| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3403455 | Indian Journal of Tuberculosis | 2016 | 9 Pages |
Abstract
MDR-TB can be cured successfully with appropriate combination of drugs if adverse events associated with them can be managed aggressively and timely. Newer and less toxic drugs are urgently needed to treat MDR-TB patients.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Infectious Diseases
Authors
Rajendra Prasad, Abhijeet Singh, Rahul Srivastava, Giridhar B. Hosmane, Ram Awadh Singh Kushwaha, Amita Jain,